Mechanical recanalization for acute ischemic stroke

Neurocritical Care

Volumn 1, Issue 3, 2004, Pages 379-383

  Nakano, Shinichi ^a   Wakisaka, Shimichiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Angioplasty; Brain; Ischemia; Mechanical; Recanalization

Indexed keywords

FIBRINOLYTIC AGENT; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

BLEEDING; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; DEVICE; ENERGY; HUMAN; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; REVIEW; SAFETY; ULTRASOUND; VIBRATION;

ANGIOPLASTY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; INTRACRANIAL THROMBOSIS; THROMBOLYTIC THERAPY;

EID: 12844276998     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:1:3:379     Document Type: Review

References (37)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Stroke Study (ECASS). JAMA 1995;274:1017-1025.
3. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS). Lancet 1998;352: 1245-1251.
4. Broderick JP. Recanalization therapies for acute ischemic stroke. Semin Neurol 1998;18:471-484.
5. Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282-1290.
6. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase-randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
7. Furlan A, Higashida R, Wechsler L, et al. for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT study: A randomized controlled trial. JAMA 1999;282:2003-2011.
8. Bovill EG, Terrin ML, Stump DC, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase-Trial. Ann Intern Med 1991;115:256-265.
9. Nakano S, Yokogami K, Ohta H, Yano T, Ohnishi T. Direct percutaneous transluminal angioplasty for acute middle cerebral aretry occlusion. AJNRAm J Neuroradiol 1998;19:767-772.
10. Yoneyama T, Nakano S, Kawano H, et al. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 2002;23:277-281.
11. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: An alternative option to intra-arterial thrombolysis. Stroke 2002;33:2872-2876.
12. Lutsep HL. Mechanical thrombolysis in acute stroke. EMedicine Neurology 2001;2.http://www.emedicine.com/neuro/topic 702.htm. Accessed June 2002.
13. Furlan AJ. Acute stroke therapy: beyond i.v. t-PA. Cleve Clin J Med 2002;69:730-734.
14. Leary MC, Saver JL, Gobin YP, et al. Beyond tissue plasminogen activator: Mechanical intervention in acute stroke. Ann Emerg Med 2003;41:838-846.
15. Ringer AJ, Tomsick TA. Developments in endovascular therapy for acute ischemic stroke. Neurol Res 2002;24:S43-S46.
16. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-1822.
17. Tsai FY, Berberian B, Matovich V, Lavin M, Alfieri K. Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR Am J Neuroradiol. 1994;15:1823-1829.
18. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke. 1998;29:2568-2574.
19. Ringer AJ, Qureshi AI, Fessier RD, Guterman LR, Hopkins LN. Angioplasty of intracranial occlusion resistant to thrombolysis in acute stroke. Neurosurgery 2001;48:1282-1288.
20. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-1329.
21. Zijlstra F, Bore MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.
22. Michels KB, Yusuf S. Does PTCAin acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-185.
23. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003:361:13-20.
24. Lutsep HL, Campbell M, Clark WM, et al. EPAR therapy system for treatment of acute stroke: Safety study results. Stroke 2001;32:319b.
25. Clark WM, Buckley LA, Nesbit GM, et al. Intraarterial laser thrombolysis therapy for clinical stroke: A feasible study. Stroke 2000;31:307.
26. Bellon RJ, Putman CM, Budzik RF, Pergolizzi RS, Reinking GF, Norbash AM. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:526-530.
27. Chopko BW, Kerber C, Wong W, Georgy B. Transcatheter snare removal of acute middle cerebral artery thromboembolism: Technical case report. Neurosurgery 2000;46:1529-1531.
28. Wikholm G. Transarterial embolectomy in acute stroke. AJNR Am J Neuroradiol 2003;24:892-894.
29. Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device. Necessity of flow reversal. Stroke 2002;33:2232-2235.
30. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: Challenging the concept of a rigid and universal time window. Stroke 1995;26:2219-2221.
31. Nakano S, Iseda T, Ikeda T, Yoneyama T, Wakisaka S. Thresholds of ischemia salvageable with intravenous tissue plasminogen activator therapy: Evaluation with cerebral blood flow single-photon emission computed tomographic measurements. Neurosurgery 2000;47:68-73.
32. Iseda T, Nakano S, Yano T, Suzuki Y, Wakisaka S. Time-threshold curve determined by single photon emission CT in patients with acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 2002;23:572-576.
33. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
34. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ and the rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3-13.
35. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605.
36. Ernst R, Pancioli AM, Tomsick TA, et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000;31:2552-2557.
37. Hill MD, Barber PA, Demchuk AM, et al. Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002;33:279-282.